.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Citi
Daiichi Sankyo
Farmers Insurance
Dow
McKesson
UBS
Johnson and Johnson
Novartis
AstraZeneca

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062327

« Back to Dashboard
NDA 062327 describes ERYTHROMYCIN, which is a drug marketed by Paddock Llc, Perrigo Co, Akorn, Pharmafair, Fougera Pharms, Arbor Pharms Llc, Wockhardt, Alpharma Us Pharms, Renaissance Pharma, Mylan Pharms Inc, Lilly, Perrigo New York, Bausch And Lomb, Pharmaderm, Perrigo Co Tennessee, Elkins Sinn, Barr, Tolmar, Lyne, Ivax Sub Teva Pharms, Life Labs, G And W Labs Inc, Watson Labs, Parke Davis, Mylan, Ani Pharms Inc, Naska, Dista, Abraxis Pharm, Teva Parenteral, Baxter Hlthcare, Purepac Pharm, and Lederle, and is included in fifty-nine NDAs. It is available from thirty-two suppliers. Additional details are available on the ERYTHROMYCIN profile page.

The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are ninety-eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.

Summary for NDA: 062327

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength2%
Approval Date:Apr 19, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Farmers Insurance
Johnson and Johnson
Harvard Business School
Cantor Fitzgerald
US Department of Justice
Deloitte
McKinsey
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot